Chinese Carmakers Double EU Market Share as EV Registrations Fuel Growth in Early 2026
Pembroke Management Reduces Q2 Holdings Stake in 142 Million FirstQuarter Sale
Prediction Market Investments Persist Despite Regulatory Uncertainty
Gold Price Outlook Could the Precious Metal Reach 6000 by 2026
The Mandalorian and Grogu Achieves Record Rotten Tomatoes Audience Score Amid CriticAudience Divide
Suze Orman Warns Americans Underestimate Critical Retirement Healthcare Cost
Everspin Technologies Q1 2026 Earnings EPS Beat Drives Positive Market Response
GAING Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Falls Short
Halozyme Therapeutics Q1 2026 Earnings EPS Beat Drives Modest Positive Surprise Despite Flat Revenue Disclosure
Amplitech Group Inc Series B Right AMPGZ Q1 2026 Earnings EPS Misses Estimates Stock Gains 69
AMZN Q1 2026 Earnings EPS Misses Estimates as Stock Edges Higher
American Shared Hospital Services AMS Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges
Tenon Medical Inc TNON Holds Steady Near 072 Support Level A Mild Uptick Amid Narrow Trading Range
Lotus Technology LOT Nears Key Support After 226 Decline
Knife Riv Holding Co KNF Surges 34 on Strong Volume Approaches Key Resistance
Smart Sand Inc SND Edges Higher Amidst Cautious Trading
TenLeague International TLIH Jumps 10 Key Levels in Focus
Three Signs from APEC Suggest US and China Trade Divergence Persists After Beijing Summit
MGX Q1 2026 Earnings Missed Expectations as PreRevenue Biotech Advances Gene Editing Pipeline
Manhattan Bridge Capital LOAN Slips 047 Consolidation Near Support Level
Dragonfly Energy Holdings DFLI Surges 65 Key Levels and Market Dynamics
Shoulder Innovations Inc SI Gains 267 Testing Key Resistance Levels
Vuzix Shares Slide 289 as Support Test Looms VUZI Stock Analysis
Definium Therapeutics DFTX Slides Slightly Approaches Key Support Level
First United Corporation FUNC Slips 107 as Stock Tests Key Support Levels
Via Renewables Preferred Stock VIASP Holds Steady Near Support Level
SAB Biotherapeutics SABS Slides 381 as Biotech Sector Faces Headwinds Key Support Tested